Alpha-fetoprotein promoter-regulated Herpes simplex virus thymidine kinase suicide gene system (AFP-HSV-TK)

The AFP promoter-regulated HSV-TK suicide gene system is a targeted gene therapy strategy designed specifically for the treatment of alpha-fetoprotein (AFP)-positive hepatocellular carcinoma (HCC). This system employs a tissue-specific promoter derived from the AFP gene to drive the expression of the Herpes simplex virus thymidine kinase (HSV-TK) gene exclusively within malignant liver cells that naturally express AFP. The therapeutic effect is achieved through the administration of a nucleoside analog prodrug, typically ganciclovir, which is converted by the HSV-TK enzyme into a cytotoxic metabolite. This metabolite interferes with DNA replication, leading to the selective destruction of the tumor cells while sparing normal, non-AFP-producing tissues. A critical feature of this system is the 'bystander effect,' where the toxic metabolites generated in HSV-TK-expressing cells can spread to neighboring non-transduced tumor cells via gap junctions or apoptotic vesicles, enhancing the overall anti-tumor efficacy. Despite its precision, challenges remain regarding the efficiency of gene delivery via viral or non-viral vectors and the potential for 'leakiness' of the AFP promoter in non-malignant but regenerating liver tissue. Clinical and preclinical studies have focused on optimizing the promoter strength and vector safety to improve the therapeutic window for HCC patients.

Other names

AFP-TK systemAFP-HSV-TK/GCVAlpha-fetoprotein-driven thymidine kinase gene therapyHSV-TK suicide gene therapy

The system utilizes the alpha-fetoprotein (AFP) promoter to restrict the expression of the Herpes simplex virus thymidine kinase (HSV-TK) enzyme specifically to AFP-producing hepatocellular carcinoma cells. Once expressed, the HSV-TK enzyme phosphorylates the non-toxic prodrug ganciclovir (GCV) into ganciclovir monophosphate. Host cell kinases then convert this into ganciclovir triphosphate, a potent DNA polymerase inhibitor that incorporates into nascent DNA strands, causing chain termination and subsequent cell death via apoptosis.